Xinru Wang
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells.
Journal: Frontiers in pharmacology
Published: September 28, 2023
An ultrasensitive and selective near-infrared fluorescent probe for tracking carboxylesterases with large Stokes shift in living cells and mice.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: August 14, 2023
MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer.
Journal: Annals of translational medicine
Published: December 17, 2021
Study on the mechanism of Danshen-Guizhi drug pair in the treatment of ovarian cancer based on network pharmacology and in vitro experiment.
Journal: PeerJ
Published: October 08, 2021
The Landscape of Clinical Implementation of Pharmacogenetic Testing in Central China: A Single-Center Study.
Journal: Pharmacogenomics and personalized medicine
Published: September 24, 2021
High miR-3609 expression is associated with better prognosis in TNBC based on mining using systematic integrated public sequencing data.
Journal: Experimental and therapeutic medicine
Published: May 25, 2021
miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint.
Journal: Experimental cell research
Published: December 10, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026